Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigating patient eligibility for anti-amyloid monoclonal antibody treatment of Alzheimer's disease: real-world data from an Austrian psychiatric memory clinic population.
Defrancesco M, Gizewski ER, Mangesius S, Galijasevic M, Virgolini I, Kroiss A, Marksteiner J, Jehle J, Doganyigit B, Hofer A. Defrancesco M, et al. Among authors: kroiss a. BJPsych Open. 2024 Sep 23;10(5):e160. doi: 10.1192/bjo.2024.747. BJPsych Open. 2024. PMID: 39308280 Free PMC article.
Correction: Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study.
Labinsky H, Nagler LK, Krusche M, Griewing S, Aries P, Kroiß A, Strunz PP, Kuhn S, Schmalzing M, Gernert M, Knitza J. Labinsky H, et al. Among authors: kroiss a. Rheumatol Int. 2024 Oct;44(10):2055. doi: 10.1007/s00296-024-05705-2. Rheumatol Int. 2024. PMID: 39180534 Free PMC article. No abstract available.
Screening for osteoporosis in people with MS: A new risk score.
Zinganell A, Hegen H, Walde J, Bauer A, Berek K, Barket R, Auer M, Bsteh G, Donnemiller E, Egger A, Grams A, Griesmacher A, Kroiss AS, Rettenwander F, Tschallener M, Tschoner A, Berger T, Deisenhammer F, Di Pauli F. Zinganell A, et al. Among authors: kroiss as. Mult Scler Relat Disord. 2023 Jun;74:104726. doi: 10.1016/j.msard.2023.104726. Epub 2023 Apr 17. Mult Scler Relat Disord. 2023. PMID: 37098303 Free article.
Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning - A retrospective analysis.
Nilica B, Svirydenka A, Fritz J, Bayerschmidt S, Kroiss A, Gruber L, Virgolini IJ. Nilica B, et al. Among authors: kroiss a. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 May-Jun;41(3):138-145. doi: 10.1016/j.remnie.2021.04.007. Epub 2021 Apr 15. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022. PMID: 35577489
Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning. A retrospective analysis.
Nilica B, Svirydenka A, Fritz J, Bayerschmidt S, Kroiss AS, Gruber L, Virgolini IJ. Nilica B, et al. Among authors: kroiss as. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Aug 9:S2253-654X(21)00062-7. doi: 10.1016/j.remn.2021.03.004. Online ahead of print. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021. PMID: 34384731 English, Spanish.
103 results